{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:08:19Z","timestamp":1793156899604,"version":"4.5.0"},"reference-count":34,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Parathyroid-related hypercalcemia is due to primary hyperparathyroidism (PHPT) or to familial hypocalciuric hypercalcemia (FHH). PHPT can lead to complications that necessitate parathyroidectomy. FHH is a rare genetic disease resembling PHPT; surgery is ineffective. A reliable method for distinguishing FHH from PHPT is needed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To develop an easy-to-use tool to predict if a patient has PHPT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Retrospective analysis of two prospective cohorts. Development of an unsupervised risk equation (Pro-FHH).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>University hospitals in Paris, France, and Aarhus, Denmark.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>Patients (Paris: 65 with FHH, 85 with PHPT; Aarhus: 38 with FHH, 55 with PHPT) were adults with hypercalcemia and PTH concentration within normal range.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Performance of Pro-FHH to predict PHPT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Pro-FHH takes into account plasma calcium, PTH, and serum osteocalcin concentrations, and calcium-to-creatinine clearance ratio calculated from 24-hour urine collection (24h-CCCR). In the Paris cohort, area under the receiver operating characteristic curve (AUROC) of Pro-FHH was 0.961, higher than that of 24h-CCCR. With a cutoff value of 0.928, Pro-FHH had 100% specificity and 100% positive predictive value for the diagnosis of PHPT; it correctly categorized 51 of 85 patients with PHPT; the remaining 34 were recommended to undergo genetic testing. No patients with FHH were wrongly categorized. In an independent cohort from Aarhus, AUROC of Pro-FHH was 0.951, higher than that of 24h-CCCR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Pro-FHH effectively predicted whether a patient has PHPT. A prospective trial is necessary to assess its usefulness in a larger population and in patients with elevated PTH concentration.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2017-02773","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T18:04:59Z","timestamp":1525284299000},"page":"2534-2542","source":"Crossref","is-referenced-by-count":38,"title":["Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia"],"prefix":"10.1210","volume":"103","author":[{"given":"Jean-Philippe","family":"Bertocchio","sequence":"first","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, D\u00e9partement de Physiologie, Paris, France"},{"name":"Universit\u00e9 Paris Descartes, Facult\u00e9 de M\u00e9decine, Paris, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de l\u2019Enfant et de l\u2019Adulte, Paris, France"},{"name":"INSERM, UMRS1138, Centre de Recherche des Cordeliers, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Tafflet","sequence":"additional","affiliation":[{"name":"INSERM, U970, Paris Cardiovascular Research Center, University Paris Descartes, Sorbonne Paris Cit\u00e9, UMR-S970, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e9nie","family":"Koumakis","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Cochin, Service de Rhumatologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Maruani","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, D\u00e9partement de Physiologie, Paris, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de l\u2019Enfant et de l\u2019Adulte, Paris, France"},{"name":"Assistance Publique-H\u00f4pitaux de Paris, Institut Necker-Enfants Malades, INSERM U1151 \u2013CNRS UMR 8253, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Vargas-Poussou","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de l\u2019Enfant et de l\u2019Adulte, Paris, France"},{"name":"INSERM, UMRS1138, Centre de Recherche des Cordeliers, Paris, France"},{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, Service de G\u00e9n\u00e9tique, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Silve","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Cochin, Biochimie et G\u00e9n\u00e9tique Mol\u00e9culaires, Paris, France"},{"name":"INSERM, U1169, Universit\u00e9 Paris Sud, H\u00f4pital Bic\u00eatre, Le Kremlin Bic\u00eatre, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Rares du M\u00e9tabolisme du Phosphore et du Calcium Fili\u00e8re de Sant\u00e9 Maladies Rares OSCAR, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H","family":"Nissen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus N, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Baron","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, D\u00e9partement de Physiologie, Paris, France"},{"name":"Universit\u00e9 Paris Descartes, Facult\u00e9 de M\u00e9decine, Paris, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de l\u2019Enfant et de l\u2019Adulte, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Prot-Bertoye","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, D\u00e9partement de Physiologie, Paris, France"},{"name":"Universit\u00e9 Paris Descartes, Facult\u00e9 de M\u00e9decine, Paris, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de l\u2019Enfant et de l\u2019Adulte, Paris, France"},{"name":"INSERM, UMRS1138, Centre de Recherche des Cordeliers, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Courbebaisse","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, D\u00e9partement de Physiologie, Paris, France"},{"name":"Universit\u00e9 Paris Descartes, Facult\u00e9 de M\u00e9decine, Paris, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de l\u2019Enfant et de l\u2019Adulte, Paris, France"},{"name":"Assistance Publique-H\u00f4pitaux de Paris, Institut Necker-Enfants Malades, INSERM U1151 \u2013CNRS UMR 8253, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Souberbielle","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, Institut Necker-Enfants Malades, Laboratoires d\u2019Explorations Fonctionnelles, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, THG, Aarhus University Hospital, Aarhus C, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cormier","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Cochin, Service de Rhumatologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Houillier","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou, D\u00e9partement de Physiologie, Paris, France"},{"name":"Universit\u00e9 Paris Descartes, Facult\u00e9 de M\u00e9decine, Paris, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de l\u2019Enfant et de l\u2019Adulte, Paris, France"},{"name":"INSERM, UMRS1138, Centre de Recherche des Cordeliers, Paris, France"},{"name":"CNRS, ERL8228, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"issue":"3","key":"2020071623145495200_B1","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071623145495200_B2","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.surg.2013.06.051","article-title":"The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record","volume":"154","author":"Press","year":"2013","journal-title":"Surgery"},{"issue":"4","key":"2020071623145495200_B3","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2014-3708","article-title":"Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology","volume":"100","author":"Cipriani","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2020071623145495200_B4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jama.2017.1620","article-title":"The definitive management of primary hyperparathyroidism: who needs an operation","volume":"317","author":"Campbell","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"2020071623145495200_B5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"issue":"10","key":"2020071623145495200_B6","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jc.2014-2000","article-title":"The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Udelsman","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071623145495200_B7","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0022-3476(72)80232-4","article-title":"Familial benign hypercalcemia","volume":"81","author":"Foley","year":"1972","journal-title":"J Pediatr"},{"issue":"3","key":"2020071623145495200_B8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1210\/jcem-72-3-541","article-title":"Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism","volume":"72","author":"Firek","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2020071623145495200_B9","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"issue":"4","key":"2020071623145495200_B10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ng0792-295","article-title":"The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families","volume":"1","author":"Chou","year":"1992","journal-title":"Nat Genet"},{"issue":"26","key":"2020071623145495200_B11","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit \u03b111 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"2020071623145495200_B12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng.2492","article-title":"Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3","volume":"45","author":"Nesbit","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"2020071623145495200_B13","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/JME-16-0124","article-title":"Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis","volume":"57","author":"Hannan","year":"2016","journal-title":"J Mol Endocrinol"},{"issue":"5","key":"2020071623145495200_B14","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1210\/jc.2015-3442","article-title":"Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: similarities and differences","volume":"101","author":"Vargas-Poussou","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071623145495200_B15","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.surg.2011.09.011","article-title":"The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: how low can parathyroid hormone go","volume":"150","author":"Wallace","year":"2011","journal-title":"Surgery"},{"issue":"10","key":"2020071623145495200_B16","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2020071623145495200_B17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"2020071623145495200_B18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2265.2008.03259.x","article-title":"Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods","volume":"69","author":"Christensen","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071623145495200_B19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1530\/EJE-13-0224","article-title":"Muscle function and quality of life are not impaired in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene (CASR)","volume":"169","author":"Jakobsen","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2020071623145495200_B20","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1210\/jc.2002-021404","article-title":"Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone","volume":"88","author":"Maruani","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"7929","key":"2020071623145495200_B21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","article-title":"Nomogram for derivation of renal threshold phosphate concentration","volume":"2","author":"Walton","year":"1975","journal-title":"Lancet"},{"issue":"11","key":"2020071623145495200_B22","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1210\/jc.2008-2484","article-title":"A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia","volume":"94","author":"Lietman","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623145495200_B23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1530\/EJE-16-0842","article-title":"AP2S1 and GNA11 mutations - not a common cause of familial hypocalciuric hypercalcemia","volume":"176","author":"Hovden","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2020071623145495200_B24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2020071623145495200_B25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4158\/EP12284.RA","article-title":"Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism","volume":"19","author":"Shinall","year":"2013","journal-title":"Endocr Pract"},{"issue":"1-2","key":"2020071623145495200_B26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"2020071623145495200_B27","doi-asserted-by":"crossref","first-page":"R229","DOI":"10.1530\/ERC-16-0059","article-title":"Endocrine neoplasms in familial syndromes of hyperparathyroidism","volume":"23","author":"Li","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"2020071623145495200_B28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/EJE-09-0257","article-title":"Association of parathyroid adenoma and familial hypocalciuric hypercalcaemia in a teenager","volume":"161","author":"Brachet","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2020071623145495200_B29","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/ccr3.657","article-title":"Multiple endocrine neoplasia phenocopy revealed as a co-occurring neuroendocrine tumor and familial hypocalciuric hypercalcemia type 3","volume":"4","author":"Hovden","year":"2016","journal-title":"Clin Case Rep"},{"issue":"2","key":"2020071623145495200_B30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0002-9343(78)90814-8","article-title":"Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism","volume":"65","author":"Marx","year":"1978","journal-title":"Am J Med"},{"key":"2020071623145495200_B31","first-page":"L29","article-title":"Letter to the editor: Distinguishing typical primary hyperparathyroidism from familial hypocalciuric hypercalcemia by using an index of urinary calcium","volume-title":"J Clin Endocrinol Metab","author":"Marx","year":"2015"},{"issue":"Pt 2","key":"2020071623145495200_B32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1258\/acb.2010.010202","article-title":"Utility of the urine calcium-to-creatinine ratio to diagnose primary hyperparathyroidism in asymptomatic hypercalcaemic patients with vitamin D deficiency","volume":"48","author":"Jayasena","year":"2011","journal-title":"Ann Clin Biochem"},{"issue":"6","key":"2020071623145495200_B33","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2265.2009.03557.x","article-title":"Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism","volume":"71","author":"Christensen","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2020071623145495200_B34","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.surg.2016.09.044","article-title":"Improving diagnostic recognition of primary hyperparathyroidism with machine learning","volume":"161","author":"Somnay","year":"2017","journal-title":"Surgery"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/7\/2534\/25123309\/jc.2017-02773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/7\/2534\/25123309\/jc.2017-02773.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T12:03:26Z","timestamp":1594987406000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/7\/2534\/4990772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-02773","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,5,2]]}}}